Aminoacyl-tRNA synthetases (ARSs) are essential for the catalysis of aminoacylation and thereby ensure high-fidelity protein synthesis; thus, the catalytic domains of ARSs are highly conserved throughout the three kingdoms 1 . Cytoplasmic ARSs have undergone substantial changes during the evolution of higher eukaryotes, including the addition of new domains with unique structural characteristics that are neither part of the enzymatic core nor present in prokaryotic homologs. Notably, these appended regions are associated with a broad range of biological functions; thus, ARSs have emerged as a new class of regulatory proteins with roles beyond protein synthesis. The activity of many ARSs in higher eukaryotes appears to be regulated by their presence in a cytoplasmic depot system called the 'MSC' , which is assembled in most cases via the appended domains and consists of eight tRNA synthetases, including EPRS, and three auxiliary ARS-interacting multifunctional proteins AIMP1 (p43), AIMP2 (p38) and AIMP3 (p18) 2, 3 .
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Aminoacyl-tRNA synthetases (ARSs) are essential for the catalysis of aminoacylation and thereby ensure high-fidelity protein synthesis; thus, the catalytic domains of ARSs are highly conserved throughout the three kingdoms 1 . Cytoplasmic ARSs have undergone substantial changes during the evolution of higher eukaryotes, including the addition of new domains with unique structural characteristics that are neither part of the enzymatic core nor present in prokaryotic homologs. Notably, these appended regions are associated with a broad range of biological functions; thus, ARSs have emerged as a new class of regulatory proteins with roles beyond protein synthesis. The activity of many ARSs in higher eukaryotes appears to be regulated by their presence in a cytoplasmic depot system called the 'MSC' , which is assembled in most cases via the appended domains and consists of eight tRNA synthetases, including EPRS, and three auxiliary ARS-interacting multifunctional proteins AIMP1 (p43), AIMP2 (p38) and AIMP3 (p18) 2, 3 .
Under conditions of stress, several MSC components, including EPRS, methionyl-tRNA synthetase (MRS), lysyl-tRNA synthetase (KRS), AIMP1 and AIMP2, are released from the complex through post-translational modifications to exert activities during non-translational events such as inflammation 4 , cell metabolism 5 , angiogenesis 6 and tumorigenesis 7 . Phosphorylation is the critical regulatory mechanism that determines the non-translational function of ARSs in cells [8] [9] [10] . A representative example of this involves EPRS, the only bifunctional tRNA synthetase; EPRS comprises glutamyl-tRNA synthetase (ERS) and prolyl tRNA synthetase (PRS), which are coupled together via a linker containing three WHEP domains (named for a subset of synthetases (tryptophanyl-tRNA synthetase (W), histidyltRNA synthetase (H) and EPRS (EP)) with this domain). EPRS is thought to reside at the exterior of the MSC 11 , consistent with its susceptibility to inducible release 9, 12 . The residues Ser886 and Ser999 located between the ERS and PRS domains of EPRS are sequentially phosphorylated following stimulation by interferon-γ (IFN-γ), which promotes its dissociation from the MSC. Once EPRS escapes the MSC, it associates with nonstructural-protein-1-associated protein 1 (NSAP1), phosphorylated ribosomal protein L13a and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to form the IFN-γ-activated inhibitor of translation (GAIT) complex 13 . This regulatory complex binds to distinct 3′ untranslated regions (UTRs) of mRNAs that encode inflammatory proteins such as ceruloplasmin and thus suppresses their translation 3, 4, 14, 15 . This specific function is thought to contribute to the resolution of chronic inflammation by controlling the expression of injurious pro-inflammatory molecules generated in response to the initial insults during infection 4 . We note that IFN-γ is produced in the context of an adaptive immune response during the late phase of infection and is secreted mainly by interleukin-12 (IL-12)-activated natural killer cells or type 1 helper T cells 16, 17 .
The innate immune response is the first line of defense during the early phase of infection. Antiviral signaling is an essential cellular process that has evolved to respond to viral infection. Signaling is mainly mediated by RIG-I-like receptor (RLR) pathways, which include the key cytosolic sensors RIG-I and MDA5, which detect viral RNA 18 . These sensors subsequently interact with the central antiviral signaling protein MAVS, which in turn activates the transcription factors NF-κB and IRF3 via the cytosolic kinases IKK and TBK1, respectively; this cascade ultimately leads to induction of type I interferons and other antiviral molecules 18, 19 . These signaling pathways are finely tuned by positive and negative regulatory mechanisms, which control antiviral responses through a complex network of proteins [20] [21] [22] .
We hypothesized that the MSC, acting as a stimulus-dependent depot system, might be involved in the regulation of additional immune responses that specifically target viral infection. We found that one of the MSC components, EPRS, protected MAVS from its negative regulator PCBP2 ('poly(rC)-binding protein 2') via infectionspecific modification and thereby facilitated the induction of antiviral innate immune responses. Thus, the MSC, which can respond rapidly to stress conditions without the need to activate gene transcription or protein synthesis, might also act as an immunoregulatory system directed against viral infection.
RESULTS

EPRS regulates immune responses to viral infection
ARSs have important roles in diverse non-translational cellular processes 1 , but there is limited information about their role(s) during viral infection. Thus, we conducted a transcriptome analysis using RNA A r t i c l e s sequencing to assess the expression patterns of the genes encoding MSC components following infection of human bronchial epithelial cells with influenza A virus (PR8). We observed both heterogeneous expression and temporal fluctuation of these genes (Fig. 1a) , which suggested a possible role for ARSs in responses to viral infection. We then assessed the ability of the MSC proteins to trigger antiviral responses and found that EPRS induced marked activity of the promoter of the gene encoding IFN-β (IFNB) (Fig. 1b) . In addition, the expression of both EPRS mRNA and protein was slightly upregulated in multiple cell lines following viral infection ( Supplementary Fig. 1a,b) .
Interferon-stimulated genes were also induced under the same conditions (Supplementary Fig. 1c ). To evaluate whether induction of EPRS mRNA was caused by type I interferon, we treated human macrophage-like U937 cells and RAW264.7 mouse macrophages with IFN-β. Treatment with IFN-β resulted in substantial upregulation of expression of the ubiquitin-like protein ISG15 ('interferon-stimulated gene 15′) but had little effect on the expression of EPRS mRNA ( Supplementary Fig. 1d ), which suggested that the EPRS gene was not controlled directly by interferon. No induction of EPRS mRNA was observed in cells depleted of RIG-I ( Supplementary Fig. 1e ), which indicated a requirement for sensing by the immune system in the induction of EPRS expression during infection with an RNA virus. Small interfering RNA (siRNA)-mediated knockdown of EPRS in RAW264.7 cells (Supplementary Fig. 2a ) increased the replication of RNA viruses (PR8 and vesicular stomatitis virus (VSV)) (Fig. 1c,d ) but did not affect the replication of herpes simplex virus (HSV), a DNA virus (Supplementary Fig. 2b ). Cells in which EPRS was knocked down showed considerable attenuation of the production of antiviral cytokines (IFN-β and IL-6) following viral infection or treatment with the synthetic double-stranded RNA poly(I:C) (Fig. 1e,f) . HSV did not significantly alter cytokine induction (Fig. 1e,f) . Similar results were obtained after viral infection of HEK293T human embryonic kidney cells in which EPRS was knocked down ( Supplementary  Fig. 2c-e) and RAW264.7 stably transduced with short hairpin RNA for knockdown of EPRS (Supplementary Fig. 2f-l) . Furthermore, activation of the interferon-related signaling molecules IRF3 and STAT1 was significantly lower in cells in which EPRS was knocked down than in their EPRS-sufficient counterparts (Fig. 1g) . In contrast, RAW264.7 cells stably overexpressing EPRS ( Supplementary  Fig. 2m ) showed significantly less viral replication and more production of IFN-β and IL-6 following infection with PR8 ( Fig. 1h-j) or VSV ( Supplementary Fig. 2n-p 
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A r t i c l e s VSV and found that the viral titer in Eprs +/− BMDMs was much higher than that in wild-type BMDMs (Fig. 2a) . Consistent with that observation, the concentration of IFN-β and IL-6 produced by Eprs +/− BMDMs was significantly lower than that produced by Eprs +/+ cells in response to both viral infection ( Fig. 2b) and treatment with poly(I:C) (Fig. 2c) . Similar results were obtained following siRNA-mediated knockdown of EPRS in mouse BMDMs ( Supplementary Fig. 3a-d) .
Moreover, the expression of Ifnb and genes encoding antiviral interferon-related and inflammation-related products was much lower in VSV-infected Eprs +/− BMDMs than in their Eprs +/+ counterparts (Fig. 2d) . The induction of genes encoding antiviral products was also much lower following PR8 infection of RAW264.7 cells in which EPRS was knocked down than that in similarly infected cells in which EPRS was not knocked down ( Supplementary Fig. 3e ). In contrast, there was no substantial difference between HSV-infected Eprs +/+ BMDMs and HSV-infected Eprs +/− BMDMs in their viral replication or cytokine secretion ( Supplementary Fig. 3f,g ). Next, we challenged Eprs +/+ and Eprs +/− mice intravenously with the VSV Indiana strain and monitored their survival daily. We found that 43% of Eprs +/− mice (6 of 14) but only 7% of Eprs +/+ mice (1 of 15) died within 6 d of infection (Fig. 3a) . To investigate the viral load in mouse tissue, we sampled and analyzed the brain and spleen of mice at day 5 after viral infection. Viral titers in the brain and spleen of Eprs +/− mice were significantly higher than in those of EPRS +/+ mice (Fig. 3b,c) , which indicated that Eprs +/− mice were more susceptible to VSV infection. To further assess the functional importance of EPRS during immune responses, we gave Eprs +/+ and Eprs +/− mice intravenous injection of recombinant VSV expressing green fluorescent protein (GFP) and measured the viral load and expression of antiviral cytokines in serum samples 12 h after infection. Viremia was greater ( Fig. 3d ) and the concentration of IFN-β, IFN-α and IL-6 in the serum was lower (Fig. 3e) in Eprs +/− mice than in Eprs +/+ mice. Finally, we collected brain tissue samples at 0-5 d after infection and assessed the histological features induced by VSV. Hematoxylin-andeosin-stained brain sections from Eprs +/− mice showed greater infiltration by inflammatory cells (particularly around the lateral ventricle regions) than that of sections from Eprs +/+ mice (Fig. 3f) . In addition, immunohistochemical analysis of sectioned brains stained with antibody to G protein of VSV (anti-VSV) confirmed the presence of infected virus at sites around the inflammation, and viral clearance was slower in Eprs +/− mice than in Eprs +/+ mice (Fig. 3g) . Together these results supported the concept that EPRS was involved in mouse intracellular innate immune responses to viral infection.
Infection-specific modification of EPRS
Published studies have shown that post-translational modifications, mainly phosphorylation, are key drivers of the release of ARSs from the MSC 9,23 and subsequent interaction with downstream effector molecules, as well as for activation of non-canonical functions 3, 24 . For example, IFN-γ-dependent sequential phosphorylation of EPRS at 
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Ser886 and Ser999 induces its release from the MSC to form the GAIT complex 13, 25 . To assess the function of EPRS following viral infection, we infected U937 cells, which are the main cell type used for the study of EPRS in the context of IFN-γ activation 13 , with PR8. Notably, the interaction of EPRS with KRS and AIMP3 was significantly reduced following virus infection (Fig. 4a) , suggestive of dissociation of EPRS from the MSC. Immunoblot analysis with an antibody that targets NSAP1, a component of the pre-GAIT complex that directly binds EPRS via phosphorylation at Ser886 (ref. 13) , revealed that EPRS bound weakly to NSAP1 at 12-24 h after infection. However, EPRS did not bind GAPDH (Fig. 4a) , a constituent of GAIT complex that requires phosphorylation of EPRS at Ser999 to allow formation of a functional complex 13 . Virus-induced EPRS release from the MSC was further confirmed by co-immunoprecipitation of PR8-infected RAW264.7 macrophage lysates with anti-EPRS or anti-KRS ( Supplementary Fig. 4a,b) . Confocal microscopy analysis also revealed that EPRS colocalized with KRS, but the extent of colocalization was reduced following viral infection (Fig. 4b,c and Supplementary Fig. 4c) . Notably, NSAP1, which is located mainly in the nucleus, slightly colocalized with EPRS at 12 h after infection ( Supplementary Fig. 4d) , consistent with the immunoblot analysis result (Fig. 4a) , whereas the protein was translocated to the cytoplasm and showed marked IFN-γ-mediated colocalization with EPRS at 12 h after treatment (Supplementary Fig. 4d ). These results suggested that a distinct virus-specific mechanism underlay EPRS activation.
To investigate the mechanism of EPRS activation and its role in antiviral responses, we next used a mass-spectrometry-based proteomics approach to identify specific post-translational modifications in streptavidin (Strep)-tagged EPRS ectopically expressed in HEK293T cells (Supplementary Fig. 5a ). Phosphorylation of Ser886 was detected in both uninfected and infected cells, whereas Ser999 (which is phosphorylated following IFN-γ stimulation) 13 was unmodified under all conditions (Supplementary Fig. 5b-d) . Unexpectedly, viral infection induced phosphorylation of EPRS at Ser990 (Fig. 4d  and Supplementary Fig. 5e ). To verify that finding, we generated a rabbit polyclonal antibody directed against this site by using the phosphorylated peptide 983 DGQRKDP(p)SKNQGGG 996 (where '(p)S' indicates the phosphorylated residue Ser990) as an antigen A r t i c l e s (Supplementary Fig. 5f ). Phosphorylation of EPRS at Ser990 gradually increased after infection of U937 cells with PR8 (Fig. 4e) . In contrast, IFN-γ treatment did not induce phosphorylation of Ser990 (Fig. 4e) . Similar results were obtained with other virus-or synthetic-RNA-treated cells (Supplementary Fig. 5g-j) . We also detected small amounts of Ser886 phosphorylation in uninfected cells, which increased following PR8 infection, although the increase was less than that observed after stimulation by IFN-γ (Fig. 4f) . Viral infection did not induce phosphorylation of Ser999, whereas IFN-γ stimulation clearly did (Fig. 4g) . Furthermore, viral infection did not affect the secretion of IFN-γ or suppress the expression of ceruloplasmin, a target of the GAIT complex 4 ( Supplementary Fig. 5k-m) . Published studies using ectopically expressed phosphomimetics of EPRS have indirectly shown that phosphorylation of Ser886 and Ser999 induces the release of EPRS from the MSC 13 . Thus, we ectopically expressed wild-type EPRS and its phosphomimetic mutant (S990D) and a phosphorylation-resistant mutant (S990A) to assess their involvement in the MSC. S990D did not interact with the MSC components KRS, AIMP3or MRS (Fig. 4h,i) , which (indirectly) indicated release of the modified EPRS from the MSC following infection. In contrast, association of the mutant S990A with MSC components was similar to that of wild-type EPRS (Fig. 4i) , which confirmed that the dissociation of EPRS from the MSC was dependent on modification of EPRS at Ser990. Together these results suggested that virusinduced phosphorylation of EPRS at Ser990 induced its release from the MSC to execute a function distinct from its role in the IFN-γ-activated GAIT translational silencing pathway.
EPRS interacts with PCBP2 to regulate MAVS signaling
Following the entry of a virus into cells, the intracellular sensor RIG-I is activated. RIG-I then interacts with MAVS to trigger a signaling cascade that culminates in the production of type I interferons 26 . Analysis of this signaling cascade revealed that EPRS increased RIG-I-, MDA5-, poly(I:C)-and MAVS-mediated activity of the IFNB promoter in a dose-dependent manner (Fig. 5a) . However, we observed no substantial activation of the IFNB promoter in the presence of the signaling protein TRAF3, TBK1 or IRF7 (Fig. 5b) or in Toll-like-receptor-3-expressing HEK293T cells stimulated by poly(I:C) (Fig. 5c) . These results suggested that EPRS is a positive regulator of the RIG-I-and MDA5-mediated type I interferon pathway and acts downstream of MAVS and upstream of the TRAF3 signaling axis.
To identify the EPRS-interacting molecules that regulate MAVS signaling during viral infection, we subjected Strep-EPRS-specific complexes from PR8-infected cells to proteomics analysis (Fig. 5d) . We found MSC proteins but not GAIT proteins (NSAP1, GAPDH and L13a) (data not shown). Notably, EPRS interacted with PCBP2, a protein known to trigger ubiquitination and degradation of MAVS 22 after viral infection (Fig. 5d-f) . Endogenous co-immunoprecipitation analysis confirmed the virus-induced interaction of EPRS with PCBP2 in RAW264.7 and U937 cells and that the interaction between the two proteins increased over time (Fig. 5e,f) . Furthermore, and consistent with the findings of a published study 22, 27 , following viral infection, PCBP2 translocated from the nucleus to the cytoplasm, where it colocalized with EPRS (Fig. 5g) . Fig. 4a ). (g) Confocal microcopy of endogenous EPRS (red) and PCBP2 (green) in HeLa cells at various times (left margin) after infection with PR8 (MOI = 5). Scale bars, 10 µm. NS, not significant (P > 0.05); *P < 0.01 and **P < 0.001 (Student's t-test). Data are representative of three experiments with similar results, with three independent biological replicates (a-c,e-g; mean and s.d. of triplicates in a-c) or one experiment (d).
wedges) of plasmid encoding FLAG-tagged EPRS (horizontal axis), followed by stimulation for 12 h with poly(I:C) (30 µg). (d) Silver staining (top) of Strep-EPRS complexes purified from 293T cells 24 h after transfection with a plasmid encoding Strep-EPRS, followed by infection for 6 h with PR8-GFP (MOI = 5): left margin, size in kilodaltons (kDa); right margin, Strep-tagged full-length EPRS (170 kDa); *, PCBP2 (38 kDa). Below, sequences of peptides identified by mass spectrometry. (e,f) Immunoassay of the interaction between EPRS and PCBP2 in PR8-infected RAW264.7 cells (e) and U937 cells (f), assessed by immunoprecipitation with anti-EPRS, followed by immunoblot analysis with anti-PCBP2 (input, as in
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To identify the EPRS region responsible for the interaction with PCBP2, we generated plasmid constructs encoding various EPRS domains (Fig. 6a) . We then performed co-immunoprecipitation to assess the interactions between each EPRS region and PCBP2. Our results revealed that the amino-terminal domain of EPRS (amino acids , which contains the glutathione S-transferase (GST)-like domain and linker region L1, was crucial for the interaction with PCBP2 and that it induced IFNB promoter activity comparable with that induced by full-length EPRS (Fig. 6a-e) . However, the GST-like domain alone (amino acids 1-168) did not induce antiviral activity (Fig. 6a-e) . These results suggested that the L1 region (amino acids between the GST-like domain and ERS was necessary for both the interaction with PCBP2 and for the antiviral responses. We confirmed those results by showing that mutant EPRS with deletion of L1 did not interact with PCBP2 and showed diminished ability to activate the IFNB promoter (Fig. 6f,g ).
On the other hand, we found that the amino-terminal K-homologous (KH1) domain (amino acids 1-81) of PCBP2, not the linker region, was sufficient for binding to EPRS (Fig. 6h,i ). An in vitro binding assay revealed that PCBP2 KH1 specifically interacted with the GST and L1 regions of EPRS (amino acids but not with the GST-like domain alone (amino acids 1-168) ( Fig. 6j and Supplementary Fig. 6a,b) , which further supported the finding that EPRS L1 was essential for interaction with PCBP2. Together these data indicated that Ser990-phosphorylation-driven release of EPRS from the MSC facilitated its interaction with PCBP2 and potentially regulated MAVS signaling.
We further assessed the non-translational function of EPRS in regulating antiviral immune responses through the use of a catalytic-null mutant generated by mutation of catalytic residues in the ERS domain 28 ( Supplementary Fig. 6c,d) and PRS domain 29 . The IFNB promoter activity induced by non-translational mutants was comparable with that induced by wild-type EPRS (Supplementary Fig. 6e) . Furthermore, 
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A r t i c l e s exogenous expression of wild-type EPRS or its enzymatically null mutant in 293T cells partially depleted of EPRS ( Supplementary  Fig. 6f ) resulted in reduced replication of VSV-GFP and increased production of antiviral cytokines ( Supplementary Fig. 6g-k) . Thus, these results indicated that EPRS-mediated antiviral innate immunity was exclusively dependent on its non-catalytic region.
EPRS protects MAVS from PCBP2-mediated ubiquitination
Published studies have shown that PCBP2 is expressed after viral infection and that it interacts with MAVS, which leads to ubiquitination of MAVS for proteasomal degradation 22, 27 . Thus, we hypothesized that EPRS might protect MAVS by blocking PCBP2-mediated ubiquitination. When we re-evaluated the interaction of PCBP2 with MAVS, we found that MAVS specifically interacted with the KH1 domain of PCBP2, which is the same domain that bound EPRS (Fig. 7a,b and Supplementary Fig. 7a,b) . Targeting of the same KH1 domain by EPRS and MAVS suggested that EPRS might compete with MAVS and thereby prevent its interaction with PCBP2 (Figs. 6i  and 7a) . Indeed, the interaction between PCBP2 and MAVS was significantly reduced in the presence of EPRS (Fig. 7c) . However, EPRS did not disrupt the binding of PCBP2 to the E3 ligase Itch (Fig. 7d) .
In addition, the interaction between PCBP2 and MAVS was not altered by the irrelevant protein leucyl-tRNA synthetase (Supplementary Fig. 7c,d) , which suggested that EPRS specifically competed with MAVS to bind PCBP2 KH1. Those results were confirmed by endogenous interaction assays, which revealed that the binding of PCBP2 to MAVS gradually decreased, whereas its interaction with EPRS markedly increased, after infection of RAW264.7 cells with PR8 (Fig. 7e) . These results suggested that EPRS acted to counter the endogenous binding of PCBP2 to MAVS in the infected cells.
PCBP2 accelerates ubiquitin-mediated degradation of MAVS by recruiting Itch 22 . Accordingly, we found that FLAG-tagged MAVS exogenously expressed in 293T cells was ubiquitinated by Itch and that the reaction markedly increased following the addition of PCBP2 (Fig. 7f) . EPRS-deficient cells were more susceptible to ubiquitination of MAVS (Supplementary Fig. 7e) . However, the addition of EPRS inhibited PCBP2-mediated ubiquitination of MAVS in a dose-dependent manner (Fig. 7f) . Likewise, endogenous ubiquitination of MAVS was greatly enhanced by PCBP2 but was significantly attenuated in the presence of EPRS (Fig. 7g) . Consistent with the results of the ubiquitination assay, both exogenous MAVS (Fig. 7h) and endogenous MAVS (Fig. 7i) were degraded by PCBP2, but were rescued from this degradation by the addition of EPRS. Finally, analysis of a cell-free system reconstituted with purified EPRS revealed much less PCBP2-mediated ubiquitination of MAVS (Fig. 7j) . In addition, we assessed the non-translational function of EPRS in npg A r t i c l e s regulating MAVS and found that non-catalytic EPRS protected MAVS from PCBP2-mediated ubiquitination in a manner similar to that used by wild-type EPRS (Supplementary Fig. 7f,g ). Thus, these results showed that EPRS specifically blocked PCBP2-mediated negative regulation of MAVS and thereby maintained strong antiviral immune responses.
We next assessed the correlation between EPRS phosphorylation and its antiviral effects in HEK293 cells partially depleted of EPRS, which were much more susceptible to ubiquitination of MAVS ( Supplementary Fig. 7h) ; we reconstituted the cells with wild-type EPRS, the phosphorylation-resistant mutant S990A or the phosphomimetic mutant S990D. We first assessed their effects on the ubiquitination of MAVS and found that the S990A mutant was unable to restore virus-induced ubiquitination of MAVS, whereas wild-type EPRS and S990D considerably inhibited the ubiquitination of MAVS (Supplementary Fig. 7i) . Accordingly, the amount of IFN-β and IL-6 produced in response to viral infection was greater for cells reconstituted with wild-type EPRS or S990D than for cells reconstituted with S990A (Supplementary Fig. 7j,k) . Consequently, wild-type EPRS and S990D markedly inhibited viral replication, whereas S990A was unable to rescue virus-infected cells (Supplementary Fig. 7l-n) . Together these results showed that virus-infection-induced phosphorylation of EPRS at Ser990 was the driving force that led to the antiviral roles of EPRS in regulating MAVS we identified here.
An EPRS-derived peptide shows antiviral activity Thus far, we had found that the EPRS L1 region (amino acids 168-196) was both essential for interaction with PCBP2 and responsible for promoting antiviral type I interferon signaling. We next designed a cell-penetrating peptide by fusing the protein-transduction domain of the human immunodeficiency virus type 1 regulatory protein Tat 30 to the EPRS L1 region (called 'Tat-Epep' here) and assessed its effects on antiviral activity. Tat-Epep compromised PCBP2-mediated endogenous ubiquitination of MAVS (Fig. 8a) and restored the cellular expression of MAVS (Fig. 8b) . Tat-Epep also increased the production of IFN-β and IL-6 in virus-infected cells (Fig. 8c) and reduced VSV replication in RAW264.7 cells in a dose-dependent manner (Fig. 8d,e) . However, Tat-Epep showed no substantial antiviral activity in RAW264.7 cells infected with HSV ( Supplementary Fig. 8a-c) , which suggested that Tat-Epep was specific to infection with RNA viruses. To confirm the MAVS specificity of Tat-Epep, we knocked down MAVS in RAW264.7 cells, infected the cells with VSV-GFP and then treated them with Tat-Epep. Tat-Epep did not reduce viral replication or affect cytokine induction in MAVS-deficient cells (Fig. 8f-i) . Tat-Epep had no effect on the viability of RAW264.7 or 293T cells at the concentrations tested (Supplementary Fig. 8d,e) , which indicated that the diminished viral titer was not a result of peptide-mediated cytotoxicity. These data suggested that Tat-Epep might be a potential anti-RNA virus agent that promotes MAVS stability and production of type I interferons. 
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A r t i c l e s DISCUSSION The cytoplasmic MSC might serve as a reservoir of ARSs that can respond rapidly to cellular stresses without calling for de novo transcription and translation 2 . We identified an antiviral function for EPRS, an MSC constituent, both in vitro and in vivo. Instead of IFN-γ-induced phosphorylation of EPRS at Ser999, which is critical for activation of the GAIT system, we identified a previously unknown phosphorylation site (Ser990) that was phosphorylated following viral infection. It is noteworthy that Ser990 and Ser999, which are only nine residues apart, are located in the unstructured linker region (approximately amino acids 947-1020), which is between the third WHEP domain 31 and the PRS domain 32 , and dictate different functions of EPRS. The use of multiple and selective phosphorylation sites in a high accessibility region might represent a highly efficient method of switching EPRS function in response to different stimuli. In this way, EPRS exhibits a phosphorylation 'code' similar to that of other key signaling proteins that act as nexuses for multiple pathways, as exemplified by retinoblastoma protein 33, 34 .
Bifunctional EPRS exists in dimeric form (mediated by antiparallel dimerization of the carboxy-terminal PRS domain) 32 and resides at the exterior of the MSC 4,9,11,12 . Size-exclusion chromatography revealed that the amino-terminal GST and ERS domains were not involved in the dimerization (data not shown). This unique dimeric conformation of EPRS might be important for maintaining the integrity of the MSC, as both amino-terminal GST-like domains interact with the respective GST-like domains in the dimeric AIMP2 molecule (core scaffold protein of MSC) 11 . The central WHEP domains located between the ERS and PRS domains might have a role in associating the catalytic domains with the MSC. Accordingly, phosphorylation of the serine residues in the linker region between the third WHEP domain and PRS might cause conformational changes and thereby weaken the binding of EPRS to the MSC and facilitate its release. Such unique and efficient properties of EPRS might be critical for maintaining immunological homeostasis via immunostimulatory activity following viral infection and contrasting anti-inflammatory activity after stimulation with IFN-γ. The precise mechanism by which phosphorylation induces the release of EPRS from the MSC via conformational changes should be explored further by kinase-profiling and structural-analysis studies.
MAVS acts as a critical adaptor in the RLR signaling pathway to control viral replication 35 . Cells employ many diverse mechanisms to tightly regulate MAVS and prevent unwanted responses following viral infection 36 . In addition to PCBP2 and Itch, several E3 ligases (Smurf1 (ref. 37), Gp78 (ref. 38 ) and TRIM25 (ref. 39)) regulate levels of MAVS after viral infection. Although we did not investigate the affinities of the MAVS-PCBP2 and EPRS-PCBP2 interactions, the kinetics for each were different in virus-infected cells. As has been reported for Sendai virus 22 , we observed a virus-induced interaction between PCBP2 and MAVS at 3 h after PR8 infection. Nonetheless, we found that EPRS constitutively prevented the association between PCBP2 and MAVS after viral infection, which correlated with the kinetics of Ser990 phosphorylation. In addition, it is clear that EPRS positively regulates the antiviral immune response in mice. On the other hand, IFN-γ produced by natural killer cells and T cells during the late stages of an immune response activates the GAIT system and prevents chronic and excessive accumulation of inflammatory proteins 4 . Following viral infection, the antiviral role of EPRS seems to dominate over GAITmediated gene silencing by increasing the production of type I interferons to maintain host fitness. Future studies will help to delineate the dual roles that EPRS might have in regulating immune responses. Such dual functions could include enhancing antiviral immune responses and GAIT complex formation (thereby avoiding damage to the cell as a result of excessive inflammation); these functions might depend on several parameters, including temporal kinetics, different types of stress or stimuli, and the amount of pathogen. In conclusion, this newly identified function of EPRS (positive regulation of MAVS during RLR signaling) has revealed the functional importance of the MSC as a regulator of immune responses to viral infection.
METHODS
Methods and any associated references are available in the online version of the paper.
